Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Pathology

• Publication date

  1989-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 2571297PMCID PMC1879911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine.

  2009cited by this paper
• Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside.

  1988cited by this paper
• Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam.

  1988cited by this paper
• Subchronic toxicity of orally administered (gavage and dosed-feed) theophylline in Fischer 344 rats and B6C3F1 mice.

  1988cited by this paper
• The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system.

  1988cited by this paper
• Potential use of DA1 and DA2 receptor agonists in the treatment of hypertension.

  1987cited by this paper
• Acute and subchronic toxicology of LY-195115 in rats and dogs.

  1987cited by this paper
• The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.

  1986cited by this paper
• Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists.

  1986cited by this paper
• Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.

  1985cited by this paper
• SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.

  1985cited by this paper
• The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.

  1985cited by this paper
• 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist.

  1985cited by this paper
• Cellular changes in mesenteric arteries and veins after acute perfusions of angiotensin II and vasoactive amines.

  1985cited by this paper
• The DA1 receptor agonist fenoldopam (SK & F 82526) is also an α2-adrenoceptor antagonist

  1985cited by this paper
• The response of small blood vessels in rat skin and skeletal muscle to repeated application of histamine: A chemical, topographical and electron microscopic study

  1985cited by this paper
• Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.

  1985cited by this paper
• Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.

  1984cited by this paper
• Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.

  1984cited by this paper
• Dopamine-sensitive adenylate-cyclase in rabbit superior mesenteric artery.

  1984cited by this paper
• Indirect sympathomimetic activity of dopamine

  1983cited by this paper
• A new oral renal vasodilator, fenoldopam

  1983cited by this paper
• LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.

  1983cited by this paper
• The production of small arterial lesions in nephrectomized rats by the administration of pure cathepsin D.

  1982cited by this paper
• Adrenoreceptor blockade in angiotensin-induced hypertension: effect on rat coronary arteries and myocardium.

  1982cited by this paper
• Renal vasodilators and hypertension

  1982cited by this paper
• Vascular labelling with monastral blue B.

  1982cited by this paper
• Dopamine and the kidney.

  1982cited by this paper
• Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.

  1982cited by this paper
• Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

  1982cited by this paper
• SEPARATION OF POTENT CENTRAL AND RENAL DOPAMINE AGONIST ACTIVITY IN SUBSTITUTED 6-CHLORO-2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINES

  1981cited by this paper
• The pathogenesis of small arterial lesions in nephrectomized rats by the administration of renin.

  1981cited by this paper
• Medial changes in arterial spasm induced by L-norepinephrine.

  1981cited by this paper
• The vascular dopamine receptor : a review.

  1981cited by this paper
• Actions of dopamine and apomorphine on the vasoconstrictor responses of perfused mesenteric arteries of mouse, rat and rabbit

  1981cited by this paper
• Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.

  1980cited by this paper
• Renal Vascular Activity of SK&F 38393 and Dopamine in Anesthetized Dogs

  1980cited by this paper
• Light and electron microscopic studies on rat arterial lesions induced by experimental arterial contraction

  1979cited by this paper
• A comparison of the vascular dopamine receptor with other dopamine receptors.

  1978cited by this paper
• Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides.

  1978cited by this paper
• Peripheral cardiovascular dopamine receptors.

  1977cited by this paper
• Cardiovascular response to increasing theophylline concentrations

  1977cited by this paper
• Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.

  1976cited by this paper
• Dopamine Induced Relaxation of Isolated Canine Renal, Mesenteric, and Femoral Arteries Contracted with Prostaglandin F2α

  1975cited by this paper
• The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.

  1975cited by this paper
• Dopamine receptors in the brain.

  1975cited by this paper
• Endothelial contractionin vivo : A study of the rat mesentery

  1972cited by this paper
• Cardiovascular and renal actions of dopamine: potential clinical applications.

  1972cited by this paper
• The Pharmacological Basis of Therapeutics

  1966cited by this paper
• ACUTE HYPERTENSIVE VASCULAR DISEASE. 1. RELATION BETWEEN BLOOD PRESSURE CHANGES AND VASCULAR LESIONS IN DIFFERENT FORMS OF ACUTE HYPERTENSION.

  1964cited by this paper
• Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

  1962cited by this paper
• Arterial necrosis in the rat produced by methoxamine.

  1960cited by this paper
• Morbid effects of vasopressin on the organs and vessels of rats

  1937cited by this paper

• Non-clinical cardiovascular safety testing: Current status, gaps and emerging trends.

  2025cites this paper
• Development and validation of an in vitro human model of drug-induced vascular injury

  2019cites this paper
• A bilayer small diameter in vitro vascular model for evaluation of drug induced vascular injury.

  2016cites this paper
• Scientific and Regulatory Policy Committee Points-to-consider Paper*

  2015cites this paper
• Optical Imaging Biomarkers of Drug-Induced Vascular Injury

  2015cites this paper
• Proceedings of the 2014 National Toxicology Program Satellite Symposium

  2015cites this paper
• Nonclinical Safety Biomarkers of Drug-induced Vascular Injury

  2014cites this paper
• Translation Strategy for the Qualification of Drug-induced Vascular Injury Biomarkers

  2014cites this paper
• Evaluation of von Willebrand Factor and von Willebrand Factor Propeptide in Models of Vascular Endothelial Cell Activation, Perturbation, and/or Injury

  2014cites this paper
• Cardiac, Vascular, and Skeletal Muscle Systems

  2013cites this paper
• Biomarkers: Discovery, Qualification and Application

  2013cites this paper
• MicroRNA changes in rat mesentery and serum associated with drug-induced vascular injury.

  2012cites this paper
• Evidence for the Nitric Oxide Pathway as a Potential Mode of Action in Fenoldopam-induced Vascular Injury

  2012influential citation
• Early Events in Vascular Injury in the Rat Induced by the Phosphodiesterase IV Inhibitor SCH 351591

  2010cites this paper
• In Search of Biomarkers for Drug‐Induced Vascular Injury

  2010cites this paper
• Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings

  2010cites this paper
• The use of in situ perfusion of the rat mesentery as a model to investigate vascular injury directly induced by drugs.

  2010cites this paper
• Characterization of the arteritis induced by infusion of rats with UK-61,260, an inodilator, for 24 h

  2009cites this paper
• Mesenteritis precedes vasculitis in the rat mesentery after subacute administration of a phosphodiesterase type 4 inhibitor.

  2006cites this paper
• Comparison of toxicity and toxicokinetics/pharmacokinetics of an alpha 1L-adrenoceptor agonist in rats and rhesus monkeys.

  2005cites this paper
• Drug-induced vascular injury--a quest for biomarkers.

  2005cites this paper
• Immunohistochemical study on inducible type of nitric oxide (iNOS), basic fibroblast growth factor (bFGF) and tumor growth factor-beta1 (TGF-beta1) in arteritis induced in rats by fenoldopam and theophylline, vasodilators.

  2002cites this paper
• Endothelial Hypertrophy in Acute Phase of Arteritis Induced by Fenoldopam, a Vasodilator, in Rats

  2002cites this paper
• Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats.

  2001cites this paper
• Evaluation of Plasma von Willebrand Factor as a Biomarker for Acute Arterial Damage in Rats

  2000cites this paper
• Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonists.

  2000cites this paper
• Coronary Arteriopathy in Monkeys Following Administration of CI-1020, an Endothelin A Receptor Antagonist

  1999cites this paper
• Tacrolimus (FK506)-Associated Renal Pathology.

  1997cites this paper
• The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats.

  1996cites this paper
• Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.

  1996cites this paper
• Nephrotoxicity of a new cephalosporin, DQ-2556, in rats.

  1992cites this paper
• Nephrotoxicity of a New Cephalosporin, DQ-2556, in Rats

  1992cites this paper
• Cardiovascular and adrenal proliferative lesions in Fischer 344 rats induced by long-term treatment with type III phosphodiesterase inhibitors (positive inotropic agents), isomazole and indolidan.

  1991cites this paper
• Pathologic observations in human allograft recipients treated with FK 506.

  1990cites this paper